NATURAL PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NATURAL PHARMA
Largest movements
- Receivables within one year +€32,001
up €32,001 (+38.2%), from €83,839 to €115,840
of which Trade receivables: +€27,463
- Cash +€22,948
up €22,948 (+10.8%), from €212,661 to €235,609
mainly Net result for the year (+€62,724) and Depreciation (+€48,916)
- Intangible fixed assets -€19,000
down €19,000 (-20.4%), from €93,339 to €74,339
- Stocks and contracts +€11,121
up €11,121 (+9.0%), from €124,135 to €135,256
- Tangible fixed assets -€8,378
down €8,378 (-7.8%), from €108,005 to €99,627
of which Furniture and vehicles: -€11,478
- Profit (loss) carried forward +€62,724
up €62,724 (+32.5%), from €192,704 to €255,428
- Debts after one year -€36,868
down €36,868 (-26.0%), from €141,860 to €104,992
- Trade debts +€10,305
up €10,305 (+7.0%), from €147,411 to €157,716
- Other debts +€7,364
up €7,364 (+25.7%), from €28,603 to €35,967
- Gross operating margin -€48,144
down €48,144 (-16.7%), from €288,881 to €240,737
- Staff costs -€32,259
down €32,259 (-23.7%), from €136,032 to €103,773
- Depreciation +€8,208
up €8,208 (+20.2%), from €40,708 to €48,916
- Taxes -€4,538
down €4,538 (-19.6%), from €23,137 to €18,600
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €625,141 | €662,921 | +€37,780 | +6.0% |
| Fixed assets | 21/28 | €201,344 | €173,966 | -€27,378 | -13.6% |
| Intangible fixed assets | 21 | €93,339 | €74,339 | -€19,000 | -20.4% |
| Tangible fixed assets | 22/27 | €108,005 | €99,627 | -€8,378 | -7.8% |
| Plant, machinery and equipment | 23 | €1,087 | €12,735 | +€11,647 | +1,071% |
| Furniture and vehicles | 24 | €37,236 | €25,758 | -€11,478 | -30.8% |
| Other tangible fixed assets | 26 | €69,682 | €61,134 | -€8,548 | -12.3% |
| Current assets | 29/58 | €423,798 | €488,955 | +€65,158 | +15.4% |
| Stocks and contracts in progress | 3 | €124,135 | €135,256 | +€11,121 | +9.0% |
| Stocks | 30/36 | €124,135 | €135,256 | +€11,121 | +9.0% |
| Amounts receivable within one year | 40/41 | €83,839 | €115,840 | +€32,001 | +38.2% |
| Trade receivables | 40 | €76,976 | €104,440 | +€27,463 | +35.7% |
| Other amounts receivable | 41 | €6,863 | €11,400 | +€4,538 | +66.1% |
| Cash at bank and in hand | 54/58 | €212,661 | €235,609 | +€22,948 | +10.8% |
| Deferred charges and accrued income | 490/1 | €3,162 | €2,250 | -€912 | -28.8% |
| Total equity and liabilities | 10/49 | €625,141 | €662,921 | +€37,780 | +6.0% |
| Equity | 10/15 | €222,704 | €285,428 | +€62,724 | +28.2% |
| Contributions | 10/11 | €30,000 | €30,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €192,704 | €255,428 | +€62,724 | +32.5% |
| Amounts payable | 17/49 | €402,437 | €377,493 | -€24,944 | -6.2% |
| Amounts payable after more than one year | 17 | €141,860 | €104,992 | -€36,868 | -26.0% |
| Financial debts | 170/4 | €141,860 | €104,992 | -€36,868 | -26.0% |
| Amounts payable within one year | 42/48 | €260,576 | €272,500 | +€11,924 | +4.6% |
| Current portion of amounts payable after more than one year | 42 | €36,203 | €36,868 | +€666 | +1.8% |
| Trade debts | 44 | €147,411 | €157,716 | +€10,305 | +7.0% |
| Suppliers | 440/4 | €147,411 | €157,716 | +€10,305 | +7.0% |
| Taxes, remuneration and social security | 45 | €48,361 | €41,949 | -€6,411 | -13.3% |
| Taxes | 450/3 | €30,223 | €13,388 | -€16,835 | -55.7% |
| Remuneration and social security | 454/9 | €18,138 | €28,561 | +€10,423 | +57.5% |
| Other amounts payable | 47/48 | €28,603 | €35,967 | +€7,364 | +25.7% |
| Remuneration, social security and pensions | 62 | €136,032 | €103,773 | -€32,259 | -23.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €40,708 | €48,916 | +€8,208 | +20.2% |
| Other operating charges | 640/8 | €3,052 | €1,197 | -€1,855 | -60.8% |
| Gross operating margin | 9900 | €288,881 | €240,737 | -€48,144 | -16.7% |
| Operating profit (loss) | 9901 | €109,088 | €86,851 | -€22,238 | -20.4% |
| Financial income | 75/76B | €1,141 | €997 | -€144 | -12.6% |
| Recurring financial income | 75 | €1,141 | €997 | -€144 | -12.6% |
| Financial charges | 65/66B | €6,663 | €6,524 | -€138 | -2.1% |
| Recurring financial charges | 65 | €6,663 | €6,524 | -€138 | -2.1% |
| Profit (loss) for the period before taxes | 9903 | €103,567 | €81,324 | -€22,243 | -21.5% |
| Income taxes | 67/77 | €23,137 | €18,600 | -€4,538 | -19.6% |
| Profit (loss) for the period | 9904 | €80,429 | €62,724 | -€17,705 | -22.0% |
| Profit (loss) for the period to be appropriated | 9905 | €80,429 | €62,724 | -€17,705 | -22.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.